Biofilms, Hazards They Present in the ASC Setting
The Learner Objectives of Dr. Truscott’s seminar presentation is about:
1. Identify biofilm characteristics that render them threats to optimal patient outcomes
2. Describe patient consequences of biofilm infections
3. List how we can reduce the threat of biofilms for patients undergoing surgery
Video Training
Category: Infection Control
Title: Biofilms - Hazards They Present for Ambulatory Surgery Centers
Presenter: Wava Truscott, PhD, MBA; Director of Medical Science & Education - Kimberly-Clark Healthcare
Wava Truscott, PhD., is Director of Medical Sciences & Clinical Education for Kimberly-Clark Health Care. Her doctorate is in Comparative Pathology emphasizing Microbiology, Immunology, and Pathology from the University of California. Her MBA is from the University of La Verne and her BS from Brigham Young University (BYU). Earlier in her career, Wava evaluated the safety and efficacy of medical devices at MIDECO Independent Laboratories, Managed the Biological Laboratories for the Pharmaseal Division of Baxter Healthcare, and was Vice President of Scientific Affairs for the SafeSkin Corporation. She spent years researching latex allergy from profiling the allergens derived from tapping the plantation trees, processing the latex and producing the gloves to developing ways to remove the offending proteins.
Dr. Truscott has authored over 70 articles, co-authored the Microbiological section of the AAMI Sterilization Recommended Practices, and served as the U.S. delegate to the International Standards Organization on Biocompatibility Testing of Medical Devices regarding Systemic Toxicity (ISO 10993-11) as the European Union was forming. She recently authored an extensive petition to the FDA requesting a ban on all powdered gloves used in healthcare and is currently the ASTM Chairman of the committee charged with developing test methods for medical gloves incorporated with antimicrobial agents.
About This Webinar:
A biofilm is a threat to optimal patient recovery. It is a collection of bacteria that attach tenaciously to an organic or inorganic surface and rapidly form a slimy/glue-like protective coating that shields this highly organized community of pathogens from assault soaps, disinfectants, antibiotics, the human immune defenses and even sterilization. Yet, these encased microorganisms are capable of launching either aggressive or insidious infections with remarkable stealth. This course will discuss the role of microbial biofilms in human infections generally, describe their formation sequence, explain how biofilms on poorly cleaned instruments and in the healthcare environment cause poor and often serious, patient outcomes while explaining these risks can be reduced. Patient consequences include loss of visual acuity, blood stream infections, breast implant contractures, device implant infections, severe Clostridium difficile outbreaks, tuberculosis, hepatitis, endocarditis, joint degradation, loss of muscle mass, significant disfigurement and even death.
The Learner Objectives of Dr. Truscott’s seminar presentation is about:
1. Identify biofilm characteristics that render them threats to optimal patient outcomes
2. Describe patient consequences of biofilm infections
3. List how we can reduce the threat of biofilms for patients undergoing surgery
Once you and any/all staff have reviewed this presentation, you will be eligible to receive a Certificate of Participation worth one Credit Hour of continuing education. You simply contact us at events@excellentiagroup.com requesting your certificates, using the Certificate Request Form found in the link below. You will need to provide a typed list of all participants first and last names, position title (RN ,BSN, etc.), license numbers (if professionals) and date of completion.
* Excellentia Advisory Group LLC is approved by the California Board of Registered Nursing, Provider CEP 15481: Issue Date: 4/6/2010;